NO304721B1 - Forsterket bredspektret baktericid sammensetning - Google Patents

Forsterket bredspektret baktericid sammensetning Download PDF

Info

Publication number: NO304721B1
Authority: NO; Norway
Prior art keywords: enhanced; lysostaphin; broad; nisin; bactericide
Prior art date: 1989-03-01

Application number

NO904729A

Other languages

English (en)

Norwegian (no)

Other versions

NO904729L (no

NO904729D0 (no

Inventor

Peter Blackburn

Sara-Ann Gusik

June Polak

Stephen D Rubino

Original Assignee

Ambi Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-01

Filing date

1990-10-31

Publication date

1999-02-08

1990-10-31 Application filed by Ambi Inc filed Critical Ambi Inc

1990-10-31 Publication of NO904729D0 publication Critical patent/NO904729D0/no

1990-11-15 Publication of NO904729L publication Critical patent/NO904729L/no

1999-02-08 Publication of NO304721B1 publication Critical patent/NO304721B1/no

Links

230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 73
239000000203 mixture Substances 0.000 title claims abstract description 40
108090000988 Lysostaphin Proteins 0.000 claims abstract description 64
239000003899 bactericide agent Substances 0.000 claims abstract description 51
108010062877 Bacteriocins Proteins 0.000 claims abstract description 26
239000004094 surface-active agent Substances 0.000 claims abstract description 18
241000894006 Bacteria Species 0.000 claims abstract description 17
239000002738 chelating agent Substances 0.000 claims abstract description 17
DWPCPZJAHOETAG-IMJSIDKUSA-N L-lanthionine Chemical compound OC(=O)[C@@H](N)CSC[C@H](N)C(O)=O DWPCPZJAHOETAG-IMJSIDKUSA-N 0.000 claims abstract description 13
DWPCPZJAHOETAG-UHFFFAOYSA-N meso-lanthionine Natural products OC(=O)C(N)CSCC(N)C(O)=O DWPCPZJAHOETAG-UHFFFAOYSA-N 0.000 claims abstract description 13
241000295644 Staphylococcaceae Species 0.000 claims abstract description 6
108010053775 Nisin Proteins 0.000 claims description 66
NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 claims description 65
239000004309 nisin Substances 0.000 claims description 65
235000010297 nisin Nutrition 0.000 claims description 65
230000000694 effects Effects 0.000 claims description 16
241000192125 Firmicutes Species 0.000 claims description 10
230000001580 bacterial effect Effects 0.000 claims description 10
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 9
GDSYPXWUHMRTHT-UHFFFAOYSA-N Epidermin Natural products N#CCC(C)(C)OC1OC(CO)C(O)C(O)C1O GDSYPXWUHMRTHT-UHFFFAOYSA-N 0.000 claims description 3
241000588724 Escherichia coli Species 0.000 claims description 3
241000191967 Staphylococcus aureus Species 0.000 claims description 3
241000193985 Streptococcus agalactiae Species 0.000 claims description 3
RKLXDNHNLPUQRB-TVJUEJKUSA-N chembl564271 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]2C(C)SC[C@H](N[C@@H](CC(N)=O)C(=O)NC(=O)[C@@H](NC2=O)CSC1C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NC(=C)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H]1NC(=O)C(=C\C)/NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H](NC(=O)[C@H]3N[C@@H](CC(C)C)C(=O)NC(=O)C(=C)NC(=O)CC[C@H](NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=4C5=CC=CC=C5NC=4)CSC3)C(O)=O)C(C)SC2)C(C)C)C(C)SC1)C1=CC=CC=C1 RKLXDNHNLPUQRB-TVJUEJKUSA-N 0.000 claims description 3
150000001875 compounds Chemical class 0.000 claims description 3
235000014113 dietary fatty acids Nutrition 0.000 claims description 3
239000003995 emulsifying agent Substances 0.000 claims description 3
108010064962 epidermin Proteins 0.000 claims description 3
CXTXHTVXPMOOSW-JUEJINBGSA-N epidermin Chemical compound C([C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSC[C@H](C(N[C@@H](CCCCN)C(=O)N1)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@H]1C(N2CCC[C@H]2C(=O)NCC(=O)N[C@@H](CS[C@H]1C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N\C(=C/C)C(=O)NCC(=O)N[C@H]1C(N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@H](C(N\C=C/SC2)=O)CSC1)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 CXTXHTVXPMOOSW-JUEJINBGSA-N 0.000 claims description 3
239000000194 fatty acid Substances 0.000 claims description 3
229930195729 fatty acid Natural products 0.000 claims description 3
150000004665 fatty acids Chemical class 0.000 claims description 3
125000005456 glyceride group Chemical group 0.000 claims description 3
229920000136 polysorbate Polymers 0.000 claims description 3
108010082567 subtilin Proteins 0.000 claims description 3
DEEOVDONDDERBX-MUDWFXPSSA-N (2S)-6-amino-2-[[(1S,4R,10S,19S,22S,25S,28S,31S,34R,37S,43S,46S,47S,50R,53S,56S,62S)-50-amino-43-(2-amino-2-oxoethyl)-56-(3-amino-3-oxopropyl)-10-benzyl-37-(carboxymethyl)-31-(hydroxymethyl)-28-(1H-indol-3-ylmethyl)-47,62-dimethyl-7-methylidene-22-(2-methylpropyl)-2,5,8,11,14,20,23,26,29,32,35,38,41,44,51,54,57-heptadecaoxo-53-propan-2-yl-48,60,63-trithia-3,6,9,12,15,21,24,27,30,33,36,39,42,45,52,55,58-heptadecazatetracyclo[32.24.3.34,25.015,19]tetrahexacontane-46-carbonyl]amino]hexanoic acid Chemical compound CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)C(=C)NC(=O)[C@@H]2CS[C@@H](C)[C@@H](NC1=O)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H](CO)C(=O)N[C@H]1CSC[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CS[C@@H](C)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC1=O)C(=O)N[C@@H](CCCCN)C(O)=O)C(C)C)C(=O)N2 DEEOVDONDDERBX-MUDWFXPSSA-N 0.000 claims description 2
241000606750 Actinobacillus Species 0.000 claims description 2
241000304886 Bacilli Species 0.000 claims description 2
241000186031 Corynebacteriaceae Species 0.000 claims description 2
241000588747 Klebsiella pneumoniae Species 0.000 claims description 2
241000186779 Listeria monocytogenes Species 0.000 claims description 2
241000589517 Pseudomonas aeruginosa Species 0.000 claims description 2
241000194019 Streptococcus mutans Species 0.000 claims description 2
239000002280 amphoteric surfactant Substances 0.000 claims description 2
108010055869 ancovenin Proteins 0.000 claims description 2
239000003945 anionic surfactant Substances 0.000 claims description 2
239000003795 chemical substances by application Substances 0.000 claims description 2
108010063293 cinnamycin Proteins 0.000 claims description 2
QJDWKBINWOWJNZ-OURZNGJWSA-N cinnamycin Chemical compound CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H]3CCCN3C(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H]3CNCCCC[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CSC[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CS[C@H]4C)C(=O)N[C@@H](CS[C@H]2C)C(=O)N3)NC1=O)[C@@H](O)C(O)=O)C(O)=O QJDWKBINWOWJNZ-OURZNGJWSA-N 0.000 claims description 2
108010067071 duramycin Proteins 0.000 claims description 2
SFWLDKQAUHFCBS-WWXQEMPQSA-N lancovutide Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H]2C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@@H](CCCCNC[C@H]4C(=O)N[C@@H](CC=5C=CC=CC=5)C(=O)NCC(=O)N5CCC[C@H]5C(=O)N[C@@H](CC=5C=CC=CC=5)C(=O)N[C@H]([C@@H](SC[C@H](NC(=O)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSC3C)CSC2)C(=O)N4)C)C(=O)N1)C(O)=O)[C@@H](O)C(O)=O)=O)C(C)C)C1=CC=CC=C1 SFWLDKQAUHFCBS-WWXQEMPQSA-N 0.000 claims description 2
108010037248 lantibiotic Pep5 Proteins 0.000 claims description 2
SRCAXTIBNLIRHU-JJKPAIEPSA-N lantibiotic pep5 Chemical compound N([C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N\C(=C/C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N\C(=C/C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N\C(=C(/C)S)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)C(=O)CC SRCAXTIBNLIRHU-JJKPAIEPSA-N 0.000 claims description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
-1 Na2CaEDTA Chemical compound 0.000 claims 1
241000605862 Porphyromonas gingivalis Species 0.000 claims 1
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 claims 1
DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 claims 1
238000000034 method Methods 0.000 abstract description 8
108090000765 processed proteins & peptides Proteins 0.000 abstract description 6
239000011159 matrix material Substances 0.000 abstract description 5
208000015181 infectious disease Diseases 0.000 abstract description 4
239000002904 solvent Substances 0.000 abstract description 3
230000000813 microbial effect Effects 0.000 abstract description 2
208000035143 Bacterial infection Diseases 0.000 abstract 1
208000022362 bacterial infectious disease Diseases 0.000 abstract 1
235000013305 food Nutrition 0.000 description 10
235000013336 milk Nutrition 0.000 description 10
210000004080 milk Anatomy 0.000 description 10
239000008267 milk Substances 0.000 description 10
238000004519 manufacturing process Methods 0.000 description 8
241000894007 species Species 0.000 description 8
241000191978 Staphylococcus simulans Species 0.000 description 7
241000191940 Staphylococcus Species 0.000 description 5
239000000872 buffer Substances 0.000 description 5
235000013351 cheese Nutrition 0.000 description 5
239000013612 plasmid Substances 0.000 description 5
108090000623 proteins and genes Proteins 0.000 description 5
241000194035 Lactococcus lactis Species 0.000 description 4
241000191976 Staphylococcus simulans bv. staphylolyticus Species 0.000 description 4
239000000645 desinfectant Substances 0.000 description 4
238000000855 fermentation Methods 0.000 description 4
230000004151 fermentation Effects 0.000 description 4
241000193386 Lysinibacillus sphaericus Species 0.000 description 3
235000014897 Streptococcus lactis Nutrition 0.000 description 3
210000004027 cell Anatomy 0.000 description 3
238000011109 contamination Methods 0.000 description 3
235000019249 food preservative Nutrition 0.000 description 3
239000005452 food preservative Substances 0.000 description 3
230000012010 growth Effects 0.000 description 3
244000005700 microbiome Species 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
239000000126 substance Substances 0.000 description 3
239000000725 suspension Substances 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
206010052428 Wound Diseases 0.000 description 2
230000003698 anagen phase Effects 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
239000000969 carrier Substances 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
238000011534 incubation Methods 0.000 description 2
239000007788 liquid Substances 0.000 description 2
235000013372 meat Nutrition 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
230000002335 preservative effect Effects 0.000 description 2
230000002265 prevention Effects 0.000 description 2
235000014059 processed cheese Nutrition 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
NVNLLIYOARQCIX-GSJOZIGCSA-N 1414-45-5 Chemical compound N1C(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(C(C)CC)NC(=O)C(NC(=O)C(=C/C)/NC(=O)C(N)C(C)CC)CSCC1C(=O)NC1C(=O)N2CCCC2C(=O)NCC(=O)NC(C(=O)NC(CCCCN)C(=O)NC2C(NCC(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NCC(=O)NC(CSC2C)C(=O)NC(CC(N)=O)C(=O)NC(CCSC)C(=O)NC(CCCCN)C(=O)NC2C(NC(C)C(=O)NC3C(=O)NC(C(NC(CC=4NC=NC=4)C(=O)NC(CSC3C)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)NC(CC=3NC=NC=3)C(=O)NC(C(C)C)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)=O)CSC2C)=O)=O)CSC1C NVNLLIYOARQCIX-GSJOZIGCSA-N 0.000 description 1
RNAMYOYQYRYFQY-UHFFFAOYSA-N 2-(4,4-difluoropiperidin-1-yl)-6-methoxy-n-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine Chemical compound N1=C(N2CCC(F)(F)CC2)N=C2C=C(OCCCN3CCCC3)C(OC)=CC2=C1NC1CCN(C(C)C)CC1 RNAMYOYQYRYFQY-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
208000003508 Botulism Diseases 0.000 description 1
241000193403 Clostridium Species 0.000 description 1
108010059378 Endopeptidases Proteins 0.000 description 1
102000005593 Endopeptidases Human genes 0.000 description 1
206010016952 Food poisoning Diseases 0.000 description 1
208000019331 Foodborne disease Diseases 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
241001468194 Leuconostoc mesenteroides subsp. dextranicum Species 0.000 description 1
MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
108010013639 Peptidoglycan Proteins 0.000 description 1
239000004365 Protease Substances 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
230000002009 allergenic effect Effects 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
239000012062 aqueous buffer Substances 0.000 description 1
239000003125 aqueous solvent Substances 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
210000004666 bacterial spore Anatomy 0.000 description 1
235000013361 beverage Nutrition 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
238000000576 coating method Methods 0.000 description 1
MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
229940073507 cocamidopropyl betaine Drugs 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
230000001332 colony forming effect Effects 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
235000013365 dairy product Nutrition 0.000 description 1
102000038379 digestive enzymes Human genes 0.000 description 1
108091007734 digestive enzymes Proteins 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
235000013399 edible fruits Nutrition 0.000 description 1
235000013601 eggs Nutrition 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
210000002615 epidermis Anatomy 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
235000019688 fish Nutrition 0.000 description 1
235000012041 food component Nutrition 0.000 description 1
239000005417 food ingredient Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
239000007943 implant Substances 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
239000002563 ionic surfactant Substances 0.000 description 1
238000009630 liquid culture Methods 0.000 description 1
238000002483 medication Methods 0.000 description 1
239000002609 medium Substances 0.000 description 1
230000009972 noncorrosive effect Effects 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
239000006916 nutrient agar Substances 0.000 description 1
239000002674 ointment Substances 0.000 description 1
239000005416 organic matter Substances 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
239000008188 pellet Substances 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
108010094020 polyglycine Proteins 0.000 description 1
229920000232 polyglycine polymer Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000003910 polypeptide antibiotic agent Substances 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
244000144977 poultry Species 0.000 description 1
235000013594 poultry meat Nutrition 0.000 description 1
239000002243 precursor Substances 0.000 description 1
239000000047 product Substances 0.000 description 1
238000000746 purification Methods 0.000 description 1
ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
235000021067 refined food Nutrition 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
210000004215 spore Anatomy 0.000 description 1
229940037648 staphylococcus simulans Drugs 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Plant Pathology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Environmental Sciences (AREA)
General Chemical & Material Sciences (AREA)
Wood Science & Technology (AREA)
Dentistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Agronomy & Crop Science (AREA)
Virology (AREA)
Microbiology (AREA)
Pest Control & Pesticides (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO904729A 1989-03-01 1990-10-31 Forsterket bredspektret baktericid sammensetning NO304721B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/317,627 US4980163A (en)	1989-03-01	1989-03-01	Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
PCT/US1990/001053 WO1990009739A1 (en)	1989-03-01	1990-02-27	Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection

Publications (3)

Publication Number	Publication Date
NO904729D0 NO904729D0 (no)	1990-10-31
NO904729L NO904729L (no)	1990-11-15
NO304721B1 true NO304721B1 (no)	1999-02-08

Family

ID=23234535

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO904729A NO304721B1 (no)	1989-03-01	1990-10-31	Forsterket bredspektret baktericid sammensetning

Country Status (21)

Country	Link
US (1)	US4980163A (de)
EP (1)	EP0424484B1 (de)
JP (1)	JP2984744B2 (de)
KR (1)	KR0145738B1 (de)
AT (1)	ATE109624T1 (de)
AU (1)	AU618714B2 (de)
CA (1)	CA2028140C (de)
CZ (1)	CZ279273B6 (de)
DD (1)	DD301903A9 (de)
DE (1)	DE69011460T2 (de)
DK (1)	DK0424484T3 (de)
FI (1)	FI103861B1 (de)
HU (1)	HU217574B (de)
IE (1)	IE64710B1 (de)
IL (1)	IL93527A (de)
NO (1)	NO304721B1 (de)
NZ (1)	NZ232700A (de)
PL (1)	PL163940B1 (de)
RU (1)	RU2048151C1 (de)
WO (1)	WO1990009739A1 (de)
ZA (1)	ZA901499B (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5858962A (en) *	1987-05-11	1999-01-12	Ambi Inc.	Composition for treating mastitis and other staphylococcal infections
US5260271A (en) *	1988-06-22	1993-11-09	Applied Microbiology, Inc.	Nisin compositions for use as enhanced broad range bactericides
DE3938140A1 (de) *	1989-11-16	1991-08-08	Beiersdorf Ag	Desodorierende kosmetische mittel
NO911341L (no) *	1990-04-20	1991-10-21	Haarmann & Reimer Corp	Fremgangsmaate for aa drepe gram-negative bakterier.
DK0589893T3 (da) *	1991-04-15	1996-09-09	Applied Microbiology Inc	Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori
GB9126686D0 (en) *	1991-12-17	1992-02-12	Smithkline Beecham Plc	Novel compositions
US5342612A (en) *	1991-12-20	1994-08-30	American Cyanamid Company	Compositions for the treatment of mammalian diseases
US5656591A (en) *	1992-01-23	1997-08-12	Morinaga Milk Industry Co., Ltd.	Antimicrobial agents and method for treating products therewith
DE4229707A1 (de) *	1992-09-05	1994-03-10	Beiersdorf Ag	Germicide Wirkstoffkombinationen
DE4307352A1 (de) *	1992-10-29	1994-05-05	Denecke Rainer Dr Med Vet	Präparat zur Therapie und insbesondere Prophylaxe von Erkrankungen des Verdauungstraktes
WO1994009806A1 (de) *	1992-10-29	1994-05-11	Rainer Denecke	Präparat zur therapie und insbesondere prophylaxe von erkrankungen des verdauungstraktes
GB9224598D0 (en) *	1992-11-24	1993-01-13	Smithkline Beecham Plc	Novel compositions
IL107887A (en) *	1992-12-08	2003-07-06	Ambi Inc	Stabilized lanthionine containing bacteriocin compositions
US5368845A (en) *	1993-01-07	1994-11-29	Colgate Palmolive Company	Oral composition
US5512269A (en) *	1993-06-09	1996-04-30	Burroughs Wellcome, Co.	Method of treating retained pulmonary secretions
DE69427492T2 (de) *	1993-08-20	2002-04-18	Novartis Ag, Basel	Verfahren zur prävention und behandlung der rindermastitis
CA2121989A1 (en) *	1993-11-18	1995-05-19	Aloysius Knipper	Thermal abuse resistant egg
US5650320A (en) *	1994-04-20	1997-07-22	University Of Alabama At Birmingham Research Foundation	Lanthionine antibiotic compositions and methods
RU2143489C1 (ru) *	1994-11-25	1999-12-27	Нижегородский научно-исследовательский институт эпидемиологии и микробиологии	Способ получения лизостафина
US5762948A (en) *	1995-06-07	1998-06-09	Ambi Inc.	Moist bacteriocin disinfectant wipes and methods of using the same
BR9609281A (pt) *	1995-06-23	1999-06-15	Ambi Inc	Método para o controle de bactérias gram-positivas resistentes a antibióticos e tratamento de infecções
US5703040A (en) *	1995-11-22	1997-12-30	Kansas State University Research Foundation	Broad spectrum antibiotic peptide
US5804549A (en) *	1996-01-05	1998-09-08	Ambi Inc.	Compositions with activity against helicobacter
US6086894A (en) *	1996-06-27	2000-07-11	Virginia Tech Intellectual Properties, Inc.	Recombinant vaccine for diseases caused by encapsulated organisms
US5932547A (en) *	1996-07-03	1999-08-03	Alza Corporation	Non-aqueous polar aprotic peptide formulations
US5916582A (en) *	1996-07-03	1999-06-29	Alza Corporation	Aqueous formulations of peptides
CZ433898A3 (cs) *	1996-07-03	1999-04-14	Alza Corporation	Nevodné protické peptidové formulace
US5910479A (en) *	1996-10-18	1999-06-08	Ambi Inc.	Method for the treatment of Streptococcus pneumoniae infection
US6238377B1 (en)	1997-01-27	2001-05-29	Jin-Zhou Liu	Nasal-nasopharyngeal cleaning system
ZA984591B (en) *	1997-06-09	1998-12-08	Ambi Inc	A method for the treatment of diarrheal disease and for elmininating particular bacterial populations from the colon
US6028051A (en) *	1997-07-23	2000-02-22	Ambi Inc.	Method for the treatment of staphylococcal disease
US6315996B1 (en)	1999-04-09	2001-11-13	Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College	Topical lysostaphin therapy for staphylococcus ocular infections
US6187768B1 (en)	1999-06-01	2001-02-13	Becton, Dickinson And Company	Kit for flushing medical devices and method of preparation
US6342385B1 (en)	2000-07-28	2002-01-29	The Uab Research Foundation	Mutacin I biosynthesis genes and proteins
DE60217297T2 (de) *	2001-02-17	2007-10-04	Novozymes A/S	Verminderung von unangenehmen gerüchen von wäsche
US7572439B2 (en) *	2002-03-26	2009-08-11	Biosynexus Incorporated	Enzyme disruption of bacterial biofilms
RU2241339C2 (ru) *	2002-09-19	2004-12-10	Общество с ограниченной ответственностью "ЛЕНОК-М"	Способ производства консервов "зелёный горошек" из сушёного зерна
MXPA05004121A (es) *	2002-10-18	2006-02-17	Molichem Medicines Inc	Metodos para tratar la enfermedad de ojo reseco con lantibioticos.
AU2003296937A1 (en) *	2002-12-10	2004-06-30	Biosynexus Incorporated	Topical anti-infective formulations
US20100221237A1 (en) *	2003-03-26	2010-09-02	Biosynexus Incorporated	Enzyme disruption of bacterial biofilms
US6989370B2 (en) *	2003-05-01	2006-01-24	The United States Of America As Represented By The Secretary Of Agriculture	Bacteriocins and novel bacterial strains
MXPA06002068A (es) *	2003-08-22	2006-05-19	Danisco	Material antimicrobiano encapsulado.
JP4926707B2 (ja) *	2003-08-22	2012-05-09	ダニスコエイ／エス	封入化抗菌材料
US20050058673A1 (en)	2003-09-09	2005-03-17	3M Innovative Properties Company	Antimicrobial compositions and methods
JP2008533048A (ja)	2005-03-10	2008-08-21	スリーエムイノベイティブプロパティズカンパニー	耳の感染症の治療方法
EP2497460A1 (de)	2005-03-10	2012-09-12	3M Innovative Properties Co.	Verfahren zur Reduktion von mikrobieller Kontamination
KR20070113281A (ko)	2005-03-10	2007-11-28	쓰리엠 이노베이티브 프로퍼티즈 컴파니	항미생물성 조성물 및 방법
EP1959740A2 (de) *	2005-11-15	2008-08-27	LG Electronics Inc.	Antimikrobielle beschichtung auf basis von kimchi-milchsäurebakterien
ATE470451T1 (de) *	2006-03-31	2010-06-15	Univ St Andrews	Antimikrobielle zusammensetzungen mit einem kationischen peptid und glycylglycin- endopeptidase
US8747872B2 (en) *	2007-05-02	2014-06-10	The Regents Of The University Of Michigan	Nanoemulsion therapeutic compositions and methods of using the same
WO2009114520A2 (en) *	2008-03-10	2009-09-17	Pharmain Corporation	Compositions for treatment with metallopeptidases, methods of making and using the same
US20090304673A1 (en) *	2008-06-10	2009-12-10	Bernd Buchberger	Method of Treatment of Inflammatory Diseases
US8425968B2 (en) *	2009-06-19	2013-04-23	Pepsico., Inc.	Beverage preservative system containing pimaricin-cyclodextrin complex
US9200251B1 (en)	2011-03-31	2015-12-01	David Gordon Bermudes	Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith
US20140090833A1 (en) *	2012-09-28	2014-04-03	Halliburton Energy Services, Inc.	Methods for Treating Wellbore and Wellbore Operation Fluids
RU2629819C1 (ru) *	2016-08-23	2017-09-04	Федеральное бюджетное учреждение науки "Казанский научно-исследовательский институт эпидемиологии и микробиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека	Антибактериальная композиция на основе хитозана и лизостафина
CN113396937A (zh) *	2020-03-17	2021-09-17	孟州云大高科生物科技有限公司	一种多酶与生物类杀菌剂的组合物
US12257346B2 (en)	2020-05-08	2025-03-25	Fertin Pharma A/S	Oral powder mixture with small sized particles

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2744827A (en) *	1951-03-07	1956-05-08	Nat Res Dev	Manufacture and preservation of cheese
GB738655A (en) *	1952-05-09	1955-10-19	Aplin & Barrett Ltd	A dry nisin preparation
US3278378A (en) *	1962-04-19	1966-10-11	Schindler Charles Alvin	Staphylococcus-derived antibiotic
US3579354A (en) *	1968-08-01	1971-05-18	Beatrice Foods Co	Preparation of an elastic cheese product
US3899594A (en) *	1971-09-13	1975-08-12	Dirigo Corp	Food preservation
US3988307A (en) *	1974-09-06	1976-10-26	The United States Of America As Represented By The Secretary Of The Department Of Health, Education And Welfare	Solid phase synthesis of peptides with carboxyl-terminal amides
PL193146A1 (pl) *	1976-10-19	1978-04-24	Inst Przemyslu Mleczarskiego	Preparat enzymatyczny do dojrzewania bialkowych produktow mleczarskich
US4318928A (en) *	1979-12-19	1982-03-09	Sing Edmond L	Preparation of cottage cheese containing Streptococcus diacetilactis
US4477471A (en) *	1982-04-15	1984-10-16	Microlife Technics, Inc.	Preservation of foods with non-lactose fermenting Streptococcus Lactis subspecies diacetilactis
US4584199A (en) *	1983-06-10	1986-04-22	Aplin & Barrett, Ltd.	Antibotulinal agents for high moisture process cheese products
US4597972A (en) *	1983-06-10	1986-07-01	Aplin & Barrett, Ltd.	Nisin as an antibotulinal agent for food products
US4716115A (en) *	1983-09-06	1987-12-29	Microlife Technics, Inc.	Derived nisin producing microorganisms, method of production and use and products obtained thereby
US4485029A (en) *	1984-03-19	1984-11-27	Minnesota Mining And Manufacturing Company	Disinfecting method and compositions
US4929445A (en) *	1988-01-25	1990-05-29	Microlife Technics, Inc.	Method for inhibiting Listeria monocytogenes using a bacteriocin

1989
- 1989-03-01 US US07/317,627 patent/US4980163A/en not_active Expired - Lifetime
1990
- 1990-02-26 IL IL9352790A patent/IL93527A/en not_active IP Right Cessation
- 1990-02-27 AU AU52850/90A patent/AU618714B2/en not_active Ceased
- 1990-02-27 CA CA002028140A patent/CA2028140C/en not_active Expired - Fee Related
- 1990-02-27 ZA ZA901499A patent/ZA901499B/xx unknown
- 1990-02-27 AT AT90904988T patent/ATE109624T1/de not_active IP Right Cessation
- 1990-02-27 HU HU849/90A patent/HU217574B/hu not_active IP Right Cessation
- 1990-02-27 JP JP2504798A patent/JP2984744B2/ja not_active Expired - Lifetime
- 1990-02-27 DE DE69011460T patent/DE69011460T2/de not_active Expired - Fee Related
- 1990-02-27 RU SU904831853A patent/RU2048151C1/ru not_active IP Right Cessation
- 1990-02-27 WO PCT/US1990/001053 patent/WO1990009739A1/en not_active Ceased
- 1990-02-27 KR KR1019900702363A patent/KR0145738B1/ko not_active Expired - Fee Related
- 1990-02-27 NZ NZ232700A patent/NZ232700A/en unknown
- 1990-02-27 EP EP90904988A patent/EP0424484B1/de not_active Expired - Lifetime
- 1990-02-27 DK DK90904988.4T patent/DK0424484T3/da active
- 1990-02-28 IE IE72190A patent/IE64710B1/en not_active IP Right Cessation
- 1990-03-01 PL PL90284095A patent/PL163940B1/pl not_active IP Right Cessation
- 1990-03-01 CZ CS90984A patent/CZ279273B6/cs not_active IP Right Cessation
- 1990-03-01 DD DD33828290A patent/DD301903A9/de unknown
- 1990-10-31 FI FI905378A patent/FI103861B1/fi not_active IP Right Cessation
- 1990-10-31 NO NO904729A patent/NO304721B1/no unknown

Also Published As

Publication number	Publication date
FI905378A0 (fi)	1990-10-31
IL93527A (en)	1995-03-15
DK0424484T3 (da)	1994-10-03
WO1990009739A1 (en)	1990-09-07
AU618714B2 (en)	1992-01-02
AU5285090A (en)	1990-09-26
HU902849D0 (en)	1991-05-28
NZ232700A (en)	1992-10-28
CZ279273B6 (cs)	1995-03-15
HUT55607A (en)	1991-06-28
NO904729L (no)	1990-11-15
ATE109624T1 (de)	1994-08-15
EP0424484B1 (de)	1994-08-10
IE64710B1 (en)	1995-08-23
CA2028140A1 (en)	1990-09-02
FI103861B (fi)	1999-10-15
JP2984744B2 (ja)	1999-11-29
NO904729D0 (no)	1990-10-31
CA2028140C (en)	1996-12-03
KR0145738B1 (ko)	1998-08-01
IL93527A0 (en)	1990-11-29
JPH03504864A (ja)	1991-10-24
PL163940B1 (pl)	1994-05-31
IE900721L (en)	1990-09-01
US4980163A (en)	1990-12-25
PL284095A1 (en)	1992-09-21
DD301903A9 (de)	1994-06-30
EP0424484A1 (de)	1991-05-02
DE69011460T2 (de)	1994-12-22
FI103861B1 (fi)	1999-10-15
ZA901499B (en)	1990-11-28
DE69011460D1 (de)	1994-09-15
KR920700003A (ko)	1992-02-19
HU217574B (hu)	2000-02-28
RU2048151C1 (ru)	1995-11-20

Publication	Publication Date	Title
EP0424484B1 (de)	1994-08-10	Bakteriocine enthaltende zusammensetzungen zur verwendung als verbesserte breitspektrum-bakterizide und verfahren zur verhütung und behandlung von mikrobiellen infektionen
EP0545911B1 (de)	1996-09-11	Arzneimittel, die Lanthionin enthaltenden Bacteriozin enthalten, zur Verwendung als Bakterizide
US5753614A (en)	1998-05-19	Nisin compositions for use as enhanced, broad range bactericides
US5217950A (en)	1993-06-08	Nisin compositions for use as enhanced, broad range bactericides
US5135910A (en)	1992-08-04	Nisin compositions for use as enhanced, broad range bactericides
Costa et al.	2018	Evaluation antibacterial and antibiofilm activity of the antimicrobial peptide P34 against Staphylococcus aureus and Enterococcus faecalis
JPH03161410A (ja)	1991-07-11	ランチバイオチツク／リゾチーム配合物による微生物の増殖の制御
EP0453860A1 (de)	1991-10-30	Verfahren zur Abtötung von gram-negativen Bakterien
RU2092180C1 (ru)	1997-10-10	Антимикробная композиция
Sirtori et al.	2008	Mode of action of antimicrobial peptide P45 on Listeria monocytogenes
Bonhi et al.	2021	A comparative profile of bactericidal action of a partially purified bacteriocin from lactic acid bacteria with antibiotics.
CA1340850C (en)	1999-12-14	Nisin compositions for use as enhanced, broad range bactericides
Ross	2015	monocytogenes 5